Atlas Genetics raises $35M in series D

Molecular diagnostics company Atlas Genetics Ltd. (Trowbridge, U.K.) raised $35 million in a series D round. New investor Wondfo Biotech participated alongside existing investors Novartis Venture Funds, Consort Medical plc (LSE:CSRT), the Johnson & Johnson Innovation-JJDC unit of Johnson & Johnson (NYSE:JNJ), LSP, BB Biotech Ventures, RMI Partners and Technology Venture Partners...